Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “ras”

843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 843
Index total 30,257
Page 19 / 36

Quick answer

This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

843 results for “ras” · 30,257 patents in full index Clear search

  1. US 9308182

    Parenteral formulations of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted

  2. US 9290474

    Methods for making and using novel semi-synthetic small molecules for the treatment parasitic disease

    The Regents of the University of California · Granted Mar 22, 2016 · Expires Mar 17, 2036

    granted

  3. US 9265818

    Genetically modified Babesia parasites expressing protective tick antigens and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 23, 2016 · Expires Feb 18, 2036

    granted

  4. US 9261507

    Anti CEACAM1 antibodies and methods of using same

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  5. US 9259465

    Methods and compositions for inhibiting diseases of the central nervous system

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Feb 16, 2016 · Expires Feb 11, 2036

    granted

  6. US 9254274

    Method of treating Tourette'S disorder with GABA-aminotransferase inactivators

    Catalyst Pharmaceuticals, Inc. · Granted Feb 9, 2016 · Expires Feb 4, 2036

    granted

  7. US 9248220

    Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent

    Lutonix, Inc. · Granted Feb 2, 2016 · Expires Jan 28, 2036

    granted

  8. US 9238838

    Microrna patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Jan 19, 2016 · Expires Jan 14, 2036

    granted

  9. US 9233095

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  10. US 9233121

    Compositions and methods for the treatment of cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  11. US 9233164

    Water soluble fullerene formulations and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jan 12, 2016 · Expires Jan 7, 2036

    granted

  12. US 9226921

    Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jan 5, 2016 · Expires Dec 31, 2035

    granted

  13. US 9187497

    Substituted pyrido[3,2-e]pyrrolo[1,2-a]pyrazines as inhibitors of poly(ADP-ribose)polymerase (PARP)

    Takeda Pharmaceutical Company Limited · Granted Nov 17, 2015 · Expires Nov 12, 2035

    granted

  14. US 9180152

    Method for treating psoriasis

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  15. US 9169509

    Topoisomerase 2b as a predictor of susceptibility to anthracycline-induced cardiotoxicity

    The Board of Regents of the University of Texas System · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  16. US 9149537

    Compositions and methods for the treatment of traumatic brain injury

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  17. US 9149445

    Inhibition of glycerol-3-phosphate acyltransferase (GPAT) and associated enzymes for treatment of viral infections

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  18. US 9150588

    Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 6, 2015 · Expires Oct 1, 2035

    granted

  19. US 9138416

    Sustained-release nanoparticle compositions and methods using the same

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  20. US 9138437

    Pyrimidine substituted purine compounds as kinase (S) inhibitors

    VERASTEM, INC. · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  21. US 9139575

    Broad spectrum antiviral and antiparasitic agents

    The Regents of the University of California · Granted Sep 22, 2015 · Expires Sep 17, 2035

    granted

  22. US 9125922

    Phosphate esters of gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 8, 2015 · Expires Sep 3, 2035

    granted

  23. US 9090933

    Cancer screening by detection of ultrastructural and molecular markers

    Northwestern University · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

  24. US 9089545

    Small molecule RNase inhibitors and methods of use

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 28, 2015 · Expires Jul 23, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.